MesotheliomaCenter's

Mesothelioma-Line

Curated Journal Articles on Mesothelioma

Category Archives: Lung Cancer

Analyzing biological and molecular characteristics and genomic damage induced by exposure to asbestos.

Cancer Management and Research 2019 May 30 [Link] Ospina D, Villegas VE, Rodríguez-Leguizamón G, Rondón-Lagos M Abstract Asbestos is one of the most important occupational carcinogens. Currently, about 125 million people worldwide are exposed to asbestos in the workplace. According to global estimates, at least 107,000 people die each year from lung cancer, mesothelioma, and […]

Comments Off on Analyzing biological and molecular characteristics and genomic damage induced by exposure to asbestos.

An asbestos contaminated town in the vicinity of an asbestos-cement facility: The case study of Sibaté, Colombia.

Environmental Research 2019 May 6 [Link] Ramos-Bonilla JP, Cely-García MF, Giraldo M, Comba P, Terracini B, Pasetto R, Marsili D, Ascoli V, Lysaniuk B, Rodríguez MC, Mazzeo A, Panqueva RDPL, Baldión M, Cañón D, García-Herreros LG, Pinzón B, Hernández LJ, Silva YA Abstract INTRODUCTION: The asbestos industry began operations in Colombia in 1942, with an […]

Comments Off on An asbestos contaminated town in the vicinity of an asbestos-cement facility: The case study of Sibaté, Colombia.

Risk of mesothelioma after cessation of asbestos exposure: a systematic review and meta-regression.

International Archives of Occupational and Environmental Health 2019 April 15 [Link] Boffetta P, Donato F, Pira E, Luu HN, La Vecchia C Abstract PURPOSE: A ‘risk reversal’ has been observed for several human carcinogens following cessation of exposure, but it is unclear whether it also exists for asbestos-related mesothelioma. METHODS: We conducted a systematic review […]

Comments Off on Risk of mesothelioma after cessation of asbestos exposure: a systematic review and meta-regression.

Asbestosis and silicosis hospitalizations in Italy (2001-2015): results from the National Hospital Discharge Registry.

European Journal of Public Health 2019 February 7 [Link] Ferrante P Abstract BACKGROUND: This work is aimed at evaluating the quality of Italian hospitalizations data about asbestosis and silicosis, assessing the impact of these diseases on the national health system and providing advice related to public health. METHODS: Italian hospital discharge data (2001-15) with diagnosis […]

Comments Off on Asbestosis and silicosis hospitalizations in Italy (2001-2015): results from the National Hospital Discharge Registry.

Impact of asbestos on public health: a retrospective study on a series of subjects with occupational and non-occupational exposure to asbestos during the activity of Fibronit plant (Broni, Italy).

Journal of Public Health Research 2018 December 20 [Link] Visonà SD, Villani S, Manzoni F, Chen Y, Ardissino G, Russo F, Moretti M, Javan GT, Osculati A Abstract The goal of this study is to understand more about the role of asbestos in causing human diseases, first of all mesothelioma, by investigating a large series […]

Comments Off on Impact of asbestos on public health: a retrospective study on a series of subjects with occupational and non-occupational exposure to asbestos during the activity of Fibronit plant (Broni, Italy).

Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma.

Proceedings of the National Academy of Sciences of the United States of America 2019 January 18 [Link] Villanova T, Gesmundo I, Audrito V, Vitale N, Silvagno F, Musuraca C, Righi L, Libener R, Riganti C, Bironzo P, Deaglio S, Papotti M, Cai R, Sha W, Ghigo E, Schally AV, Granata R Abstract Malignant pleural mesothelioma […]

Comments Off on Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma.

Mesothelin-targeted second generation CAR-T cells inhibit growth of mesothelin-expressing tumors in vivo.

Experimental and Therapeutic Medicine 2019 January [Link] Ye L, Lou Y, Lu L, Fan X Abstract Non-small cell lung cancer (NSCLC) and mesothelioma are renowned for being diagnosed at a late stage and poor prognosis. Although surgery, chemotherapy, and radiotherapy have yielded successful outcomes, the improvement on the survival rate of NSCLC and mesothelioma have been less marked. […]

Comments Off on Mesothelin-targeted second generation CAR-T cells inhibit growth of mesothelin-expressing tumors in vivo.

The effect of rapid infusion of cisplatin on nephrotoxicity in patients with lung carcinoma.

Journal of Clinical Pharmacy and Therapeutics 2018 December 2018 [Link] Mense ES, Smit AAJ, Crul M, Franssen EJF Abstract WHAT IS KNOWN AND OBJECTIVE: The use of cisplatin in the treatment of lung carcinoma is limited by nephrotoxicity. The aim of this study was to determine whether the incidence of nephrotoxicity in patients with lung […]

Comments Off on The effect of rapid infusion of cisplatin on nephrotoxicity in patients with lung carcinoma.

Diagnosis of malignant pleural mesothelioma from pleural fluid by Fourier transform-infrared spectroscopy coupled with chemometrics.

Journal of Biomedical Optics 2018 October [Link] Abbas S, Simsek Ozek N, Emri S, Koksal D, Severcan M, Severcan F Abstract This study was conducted to differentiate malignant pleural mesothelioma (MPM) from lung cancer (LC) and benign pleural effusion (BPE) from pleural fluids using the diagnostic power of Fourier transform-infrared spectroscopy with attenuated total reflectance […]

Comments Off on Diagnosis of malignant pleural mesothelioma from pleural fluid by Fourier transform-infrared spectroscopy coupled with chemometrics.

Inhibiting crosstalk between MET signaling and mitochondrial dynamics and morphology: a novel therapeutic approach for lung cancer and mesothelioma.

Cancer Biology & Therapy 2018 October 12 [Link] Wang J, Mirzapoiazova T, Carol Tan YH, Pang KM, Pozhitkov A, Wang Y, Wang Y, Mambetsariev B, Wang E, Nasser MW, Batra SK, Raz D, Reckamp K, Kulkarni P, Zheng Abstract The receptor tyrosine kinase MET is frequently involved in malignant transformation and inhibiting its activity in […]

Comments Off on Inhibiting crosstalk between MET signaling and mitochondrial dynamics and morphology: a novel therapeutic approach for lung cancer and mesothelioma.